Proactiveinvestors USA & Canada Admedus Ltd https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Admedus Ltd RSS feed en Mon, 11 Nov 2019 21:22:41 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Admedus makes "transformational" sale of CardioCel® and VascuCel® for $36.2 million https://www.proactiveinvestors.com/companies/news/904705/admedus-makes--transformational--sale-of-cardiocel-and-vascucel-for-362-million-904705.html Mon, 14 Oct 2019 05:43:00 -0400 https://www.proactiveinvestors.com/companies/news/904705/admedus-makes--transformational--sale-of-cardiocel-and-vascucel-for-362-million-904705.html Admedus receives approval to sell CardioCel 3D® in Israel https://www.proactiveinvestors.com/companies/news/902058/admedus-receives-approval-to-sell-cardiocel-3d-in-israel-902058.html Wed, 04 Sep 2019 22:43:00 -0400 https://www.proactiveinvestors.com/companies/news/902058/admedus-receives-approval-to-sell-cardiocel-3d-in-israel-902058.html Admedus' CardioCell biomaterial scaffold technology validated by independent peer-reviewed study https://www.proactiveinvestors.com/companies/news/222658/admedus--cardiocell-biomaterial-scaffold-technology-validated-by-independent-peer-reviewed-study-222658.html Mon, 24 Jun 2019 07:23:00 -0400 https://www.proactiveinvestors.com/companies/news/222658/admedus--cardiocell-biomaterial-scaffold-technology-validated-by-independent-peer-reviewed-study-222658.html Admedus divests Infusion business for $6.3 million in restructure based on ADAPT portfolio growth strategy https://www.proactiveinvestors.com/companies/news/221283/admedus-divests-infusion-business-for-63-million-in-restructure-based-on-adapt-portfolio-growth-strategy-221283.html Fri, 31 May 2019 06:58:00 -0400 https://www.proactiveinvestors.com/companies/news/221283/admedus-divests-infusion-business-for-63-million-in-restructure-based-on-adapt-portfolio-growth-strategy-221283.html Admedus divesting non-core business; to focus on ADAPT product portfolio https://www.proactiveinvestors.com/companies/news/220085/admedus-divesting-non-core-business-to-focus-on-adapt-product-portfolio-220085.html Mon, 13 May 2019 01:09:00 -0400 https://www.proactiveinvestors.com/companies/news/220085/admedus-divesting-non-core-business-to-focus-on-adapt-product-portfolio-220085.html Admedus enters into agreement with SIO Partners for $1 million debt facility https://www.proactiveinvestors.com/companies/news/219870/admedus-enters-into-agreement-with-sio-partners-for-1-million-debt-facility-219870.html Wed, 08 May 2019 08:40:00 -0400 https://www.proactiveinvestors.com/companies/news/219870/admedus-enters-into-agreement-with-sio-partners-for-1-million-debt-facility-219870.html Admedus in trading halt pending update on Admedus Immunotherapies transaction https://www.proactiveinvestors.com/companies/news/218543/admedus-in-trading-halt-pending-update-on-admedus-immunotherapies-transaction-218543.html Mon, 15 Apr 2019 04:58:00 -0400 https://www.proactiveinvestors.com/companies/news/218543/admedus-in-trading-halt-pending-update-on-admedus-immunotherapies-transaction-218543.html Admedus to spin-off immunotherapies business; shares surge https://www.proactiveinvestors.com/companies/news/218288/admedus-to-spin-off-immunotherapies-business-shares-surge-218288.html Wed, 10 Apr 2019 05:14:00 -0400 https://www.proactiveinvestors.com/companies/news/218288/admedus-to-spin-off-immunotherapies-business-shares-surge-218288.html Admedus in trading halt with sale transaction news pending https://www.proactiveinvestors.com/companies/news/218285/admedus-in-trading-halt-with-sale-transaction-news-pending-218285.html Wed, 10 Apr 2019 03:22:00 -0400 https://www.proactiveinvestors.com/companies/news/218285/admedus-in-trading-halt-with-sale-transaction-news-pending-218285.html Admedus delivers results with heart-driven corporate strategy https://www.proactiveinvestors.com/companies/news/217329/admedus-delivers-results-with-heart-driven-corporate-strategy-217329.html Thu, 28 Mar 2019 21:18:00 -0400 https://www.proactiveinvestors.com/companies/news/217329/admedus-delivers-results-with-heart-driven-corporate-strategy-217329.html Admedus CEO in New York to update on recent key milestones https://www.proactiveinvestors.com/companies/news/312628/admedus-ceo-in-new-york-to-update-on-recent-key-milestones-12628.html Mon, 18 Mar 2019 00:16:00 -0400 https://www.proactiveinvestors.com/companies/news/312628/admedus-ceo-in-new-york-to-update-on-recent-key-milestones-12628.html Admedus receives European CE Mark for CardioCel 3D® and VascuCel® https://www.proactiveinvestors.com/companies/news/216130/admedus-receives-european-ce-mark-for-cardiocel-3d-and-vascucel-216130.html Sun, 10 Mar 2019 22:38:00 -0400 https://www.proactiveinvestors.com/companies/news/216130/admedus-receives-european-ce-mark-for-cardiocel-3d-and-vascucel-216130.html Admedus delivers $25.6 million in total group revenue for the 2018 financial year https://www.proactiveinvestors.com/companies/news/215576/admedus-delivers-256-million-in-total-group-revenue-for-the-2018-financial-year-215576.html Fri, 01 Mar 2019 02:14:00 -0500 https://www.proactiveinvestors.com/companies/news/215576/admedus-delivers-256-million-in-total-group-revenue-for-the-2018-financial-year-215576.html Admedus receives first data from animal study on heart valve device https://www.proactiveinvestors.com/companies/news/214825/admedus-receives-first-data-from-animal-study-on-heart-valve-device-214825.html Tue, 19 Feb 2019 00:13:00 -0500 https://www.proactiveinvestors.com/companies/news/214825/admedus-receives-first-data-from-animal-study-on-heart-valve-device-214825.html Admedus secures $8.6 million as Sio Partners becomes substantial holder https://www.proactiveinvestors.com/companies/news/212919/admedus-secures-86-million-as-sio-partners-becomes-substantial-holder-212919.html Mon, 21 Jan 2019 02:28:00 -0500 https://www.proactiveinvestors.com/companies/news/212919/admedus-secures-86-million-as-sio-partners-becomes-substantial-holder-212919.html Admedus directors show faith in company by participating in rights issue https://www.proactiveinvestors.com/companies/news/211696/admedus-directors-show-faith-in-company-by-participating-in-rights-issue-211696.html Sun, 23 Dec 2018 23:15:00 -0500 https://www.proactiveinvestors.com/companies/news/211696/admedus-directors-show-faith-in-company-by-participating-in-rights-issue-211696.html Admedus closes rights issue, secures $18.9 million https://www.proactiveinvestors.com/companies/news/211270/admedus-closes-rights-issue-secures-189-million-211270.html Sun, 16 Dec 2018 21:25:00 -0500 https://www.proactiveinvestors.com/companies/news/211270/admedus-closes-rights-issue-secures-189-million-211270.html Admedus appoints Star Bright nominees as non-executive directors https://www.proactiveinvestors.com/companies/news/211011/admedus-appoints-star-bright-nominees-as-non-executive-directors-211011.html Wed, 12 Dec 2018 01:18:00 -0500 https://www.proactiveinvestors.com/companies/news/211011/admedus-appoints-star-bright-nominees-as-non-executive-directors-211011.html Admedus appoints new chief medical officer to focus on growth opportunities https://www.proactiveinvestors.com/companies/news/210431/admedus-appoints-new-chief-medical-officer-to-focus-on-growth-opportunities-210431.html Tue, 04 Dec 2018 01:20:00 -0500 https://www.proactiveinvestors.com/companies/news/210431/admedus-appoints-new-chief-medical-officer-to-focus-on-growth-opportunities-210431.html Admedus returns to exchange and launches a $20.2 million capital raising https://www.proactiveinvestors.com/companies/news/210087/admedus-returns-to-exchange-and-launches-a-202-million-capital-raising-210087.html Wed, 28 Nov 2018 06:00:00 -0500 https://www.proactiveinvestors.com/companies/news/210087/admedus-returns-to-exchange-and-launches-a-202-million-capital-raising-210087.html Admedus appoints experienced finance executive as interim CFO https://www.proactiveinvestors.com/companies/news/209875/admedus-appoints-experienced-finance-executive-as-interim-cfo-209875.html Mon, 26 Nov 2018 02:48:00 -0500 https://www.proactiveinvestors.com/companies/news/209875/admedus-appoints-experienced-finance-executive-as-interim-cfo-209875.html Admedus reports $6.3 million revenues amid $12.7 million Star Bright backing https://www.proactiveinvestors.com/companies/news/209049/admedus-reports-63-million-revenues-amid-127-million-star-bright-backing-209049.html Tue, 13 Nov 2018 05:15:00 -0500 https://www.proactiveinvestors.com/companies/news/209049/admedus-reports-63-million-revenues-amid-127-million-star-bright-backing-209049.html Admedus appoints Steve Denaro to the board https://www.proactiveinvestors.com/companies/news/208273/admedus-appoints-steve-denaro-to-the-board-208273.html Wed, 31 Oct 2018 21:45:00 -0400 https://www.proactiveinvestors.com/companies/news/208273/admedus-appoints-steve-denaro-to-the-board-208273.html Admedus completes placement to strategic cornerstone investor Star Bright Group https://www.proactiveinvestors.com/companies/news/205083/admedus-completes-placement-to-strategic-cornerstone-investor-star-bright-group-205083.html Tue, 18 Sep 2018 05:12:00 -0400 https://www.proactiveinvestors.com/companies/news/205083/admedus-completes-placement-to-strategic-cornerstone-investor-star-bright-group-205083.html Admedus receives $3.425 million in funds from further Star Bright placement https://www.proactiveinvestors.com/companies/news/204191/admedus-receives-3425-million-in-funds-from-further-star-bright-placement-204191.html Wed, 05 Sep 2018 05:06:00 -0400 https://www.proactiveinvestors.com/companies/news/204191/admedus-receives-3425-million-in-funds-from-further-star-bright-placement-204191.html Admedus secures strategic cornerstone investor from Hong Kong https://www.proactiveinvestors.com/companies/news/204009/admedus-secures-strategic-cornerstone-investor-from-hong-kong-204009.html Sun, 02 Sep 2018 23:48:00 -0400 https://www.proactiveinvestors.com/companies/news/204009/admedus-secures-strategic-cornerstone-investor-from-hong-kong-204009.html Admedus extends successful distribution deal for medication delivery pumps https://www.proactiveinvestors.com/companies/news/202539/admedus-extends-successful-distribution-deal-for-medication-delivery-pumps-202539.html Thu, 09 Aug 2018 02:28:00 -0400 https://www.proactiveinvestors.com/companies/news/202539/admedus-extends-successful-distribution-deal-for-medication-delivery-pumps-202539.html Admedus has capital raising news imminent, granted ASX trading halt https://www.proactiveinvestors.com/companies/news/202059/admedus-has-capital-raising-news-imminent-granted-asx-trading-halt-202059.html Thu, 02 Aug 2018 02:40:00 -0400 https://www.proactiveinvestors.com/companies/news/202059/admedus-has-capital-raising-news-imminent-granted-asx-trading-halt-202059.html Admedus commences animal trials for heart valve device https://www.proactiveinvestors.com/companies/news/200528/admedus-commences-animal-trials-for-heart-valve-device-200528.html Wed, 11 Jul 2018 01:50:00 -0400 https://www.proactiveinvestors.com/companies/news/200528/admedus-commences-animal-trials-for-heart-valve-device-200528.html Admedus signs exclusive distribution agreement in Italy for its unique heart tissue product https://www.proactiveinvestors.com/companies/news/200318/admedus-signs-exclusive-distribution-agreement-in-italy-for-its-unique-heart-tissue-product-200318.html Mon, 09 Jul 2018 01:24:00 -0400 https://www.proactiveinvestors.com/companies/news/200318/admedus-signs-exclusive-distribution-agreement-in-italy-for-its-unique-heart-tissue-product-200318.html Admedus board members stand with shareholders and buy shares https://www.proactiveinvestors.com/companies/news/199835/admedus-board-members-stand-with-shareholders-and-buy-shares-199835.html Fri, 29 Jun 2018 02:37:00 -0400 https://www.proactiveinvestors.com/companies/news/199835/admedus-board-members-stand-with-shareholders-and-buy-shares-199835.html Admedus progressing towards securing $18 million investment for immunotherapies division https://www.proactiveinvestors.com/companies/news/199624/admedus-progressing-towards-securing-18-million-investment-for-immunotherapies-division-199624.html Wed, 27 Jun 2018 01:19:00 -0400 https://www.proactiveinvestors.com/companies/news/199624/admedus-progressing-towards-securing-18-million-investment-for-immunotherapies-division-199624.html Admedus to change supplier, aims to be more price competitive https://www.proactiveinvestors.com/companies/news/198413/admedus-to-change-supplier-aims-to-be-more-price-competitive-198413.html Thu, 07 Jun 2018 05:21:00 -0400 https://www.proactiveinvestors.com/companies/news/198413/admedus-to-change-supplier-aims-to-be-more-price-competitive-198413.html Admedus raises $2.76 million from share purchase plan https://www.proactiveinvestors.com/companies/news/198147/admedus-raises-276-million-from-share-purchase-plan-198147.html Mon, 04 Jun 2018 04:46:00 -0400 https://www.proactiveinvestors.com/companies/news/198147/admedus-raises-276-million-from-share-purchase-plan-198147.html Admedus appoints Catherine Costello as interim executive director https://www.proactiveinvestors.com/companies/news/197506/admedus-appoints-catherine-costello-as-interim-executive-director-197506.html Wed, 23 May 2018 05:56:00 -0400 https://www.proactiveinvestors.com/companies/news/197506/admedus-appoints-catherine-costello-as-interim-executive-director-197506.html Admedus files three new patents in the US for heart valve device https://www.proactiveinvestors.com/companies/news/197496/admedus-files-three-new-patents-in-the-us-for-heart-valve-device-197496.html Wed, 23 May 2018 01:08:00 -0400 https://www.proactiveinvestors.com/companies/news/197496/admedus-files-three-new-patents-in-the-us-for-heart-valve-device-197496.html Admedus progressing to animal trials of its unique heart valve device https://www.proactiveinvestors.com/companies/news/197410/admedus-progressing-to-animal-trials-of-its-unique-heart-valve-device-197410.html Tue, 22 May 2018 01:12:00 -0400 https://www.proactiveinvestors.com/companies/news/197410/admedus-progressing-to-animal-trials-of-its-unique-heart-valve-device-197410.html Admedus signs deal to market its heart tissue products in Spain and Portugal https://www.proactiveinvestors.com/companies/news/197148/admedus-signs-deal-to-market-its-heart-tissue-products-in-spain-and-portugal-197148.html Thu, 17 May 2018 01:13:00 -0400 https://www.proactiveinvestors.com/companies/news/197148/admedus-signs-deal-to-market-its-heart-tissue-products-in-spain-and-portugal-197148.html Admedus using capital raised to advance product development and share price growth https://www.proactiveinvestors.com/companies/news/309291/admedus-using-capital-raised-to-advance-product-development-and-share-price-growth-9291.html Tue, 15 May 2018 03:06:00 -0400 https://www.proactiveinvestors.com/companies/news/309291/admedus-using-capital-raised-to-advance-product-development-and-share-price-growth-9291.html Admedus secures $6 million to expand medical technologies strategy https://www.proactiveinvestors.com/companies/news/196696/admedus-secures-6-million-to-expand-medical-technologies-strategy-196696.html Thu, 10 May 2018 02:50:00 -0400 https://www.proactiveinvestors.com/companies/news/196696/admedus-secures-6-million-to-expand-medical-technologies-strategy-196696.html Admedus enters trading halt ahead of capital raising https://www.proactiveinvestors.com/companies/news/196501/admedus-enters-trading-halt-ahead-of-capital-raising-196501.html Tue, 08 May 2018 01:36:00 -0400 https://www.proactiveinvestors.com/companies/news/196501/admedus-enters-trading-halt-ahead-of-capital-raising-196501.html Admedus has healthy mix of reliable Infusion earnings and strong revenue growth from ADAPT https://www.proactiveinvestors.com/companies/news/196209/admedus-has-healthy-mix-of-reliable-infusion-earnings-and-strong-revenue-growth-from-adapt-196209.html Wed, 02 May 2018 05:50:00 -0400 https://www.proactiveinvestors.com/companies/news/196209/admedus-has-healthy-mix-of-reliable-infusion-earnings-and-strong-revenue-growth-from-adapt-196209.html Admedus appoints medtech expert Michael Oswell as vice president, development https://www.proactiveinvestors.com/companies/news/196098/admedus-appoints-medtech-expert-michael-oswell-as-vice-president-development-196098.html Tue, 01 May 2018 01:04:00 -0400 https://www.proactiveinvestors.com/companies/news/196098/admedus-appoints-medtech-expert-michael-oswell-as-vice-president-development-196098.html Admedus enters into letter of intent to arrange alternative funding for immunotherapies division https://www.proactiveinvestors.com/companies/news/195910/admedus-enters-into-letter-of-intent-to-arrange-alternative-funding-for-immunotherapies-division-195910.html Fri, 27 Apr 2018 01:25:00 -0400 https://www.proactiveinvestors.com/companies/news/195910/admedus-enters-into-letter-of-intent-to-arrange-alternative-funding-for-immunotherapies-division-195910.html Admedus takes significant step forward in developing unique heart valve device https://www.proactiveinvestors.com/companies/news/195314/admedus-takes-significant-step-forward-in-developing-unique-heart-valve-device-195314.html Thu, 19 Apr 2018 03:15:00 -0400 https://www.proactiveinvestors.com/companies/news/195314/admedus-takes-significant-step-forward-in-developing-unique-heart-valve-device-195314.html Admedus advances in North America with more products and markets on the horizon https://www.proactiveinvestors.com/companies/news/308904/admedus-advances-in-north-america-with-more-products-and-markets-on-the-horizon-8904.html Tue, 20 Mar 2018 12:11:00 -0400 https://www.proactiveinvestors.com/companies/news/308904/admedus-advances-in-north-america-with-more-products-and-markets-on-the-horizon-8904.html Admedus heart valve device in development passes key milestone https://www.proactiveinvestors.com/companies/news/192950/admedus-heart-valve-device-in-development-passes-key-milestone-192950.html Sun, 11 Mar 2018 22:54:00 -0400 https://www.proactiveinvestors.com/companies/news/192950/admedus-heart-valve-device-in-development-passes-key-milestone-192950.html Admedus enters agreement opening sales channel to 1,500 hospitals https://www.proactiveinvestors.com/companies/news/192889/admedus-enters-agreement-opening-sales-channel-to-1500-hospitals-192889.html Thu, 08 Mar 2018 23:37:00 -0500 https://www.proactiveinvestors.com/companies/news/192889/admedus-enters-agreement-opening-sales-channel-to-1500-hospitals-192889.html Admedus secures regulatory approval in Canada for heart tissue products https://www.proactiveinvestors.com/companies/news/192723/admedus-secures-regulatory-approval-in-canada-for-heart-tissue-products-192723.html Wed, 07 Mar 2018 00:25:00 -0500 https://www.proactiveinvestors.com/companies/news/192723/admedus-secures-regulatory-approval-in-canada-for-heart-tissue-products-192723.html Admedus appoints new company secretary and general counsel https://www.proactiveinvestors.com/companies/news/192228/admedus-appoints-new-company-secretary-and-general-counsel-192228.html Tue, 27 Feb 2018 04:46:00 -0500 https://www.proactiveinvestors.com/companies/news/192228/admedus-appoints-new-company-secretary-and-general-counsel-192228.html Admedus Ltd moving up the value chain and preparing for 'pivotal' year https://www.proactiveinvestors.com/companies/news/308683/admedus-ltd-moving-up-the-value-chain-and-preparing-for-pivotal-year-8683.html Tue, 30 Jan 2018 22:28:00 -0500 https://www.proactiveinvestors.com/companies/news/308683/admedus-ltd-moving-up-the-value-chain-and-preparing-for-pivotal-year-8683.html Admedus introduces heart tissue technology to India https://www.proactiveinvestors.com/companies/news/190862/admedus-introduces-heart-tissue-technology-to-india-190862.html Tue, 30 Jan 2018 22:20:00 -0500 https://www.proactiveinvestors.com/companies/news/190862/admedus-introduces-heart-tissue-technology-to-india-190862.html Admedus receives approval to sell CardioCel in India https://www.proactiveinvestors.com/companies/news/187668/admedus-receives-approval-to-sell-cardiocel-in-india-187668.html Wed, 22 Nov 2017 20:11:00 -0500 https://www.proactiveinvestors.com/companies/news/187668/admedus-receives-approval-to-sell-cardiocel-in-india-187668.html Admedus secures debt funding to expand business https://www.proactiveinvestors.com/companies/news/186235/admedus-secures-debt-funding-to-expand-business-186235.html Thu, 26 Oct 2017 03:46:00 -0400 https://www.proactiveinvestors.com/companies/news/186235/admedus-secures-debt-funding-to-expand-business-186235.html Admedus submits patent application and enters trading halt https://www.proactiveinvestors.com/companies/news/186070/admedus-submits-patent-application-and-enters-trading-halt-186070.html Tue, 24 Oct 2017 03:54:00 -0400 https://www.proactiveinvestors.com/companies/news/186070/admedus-submits-patent-application-and-enters-trading-halt-186070.html Admedus eyes new revenue stream through supply agreement with 4C Medical Technologies https://www.proactiveinvestors.com/companies/news/183283/admedus-eyes-new-revenue-stream-through-supply-agreement-with-4c-medical-technologies-183283.html Fri, 01 Sep 2017 03:12:00 -0400 https://www.proactiveinvestors.com/companies/news/183283/admedus-eyes-new-revenue-stream-through-supply-agreement-with-4c-medical-technologies-183283.html Admedus beats revenue forecasts for financial year 2017 https://www.proactiveinvestors.com/companies/news/183196/admedus-beats-revenue-forecasts-for-financial-year-2017-183196.html Thu, 31 Aug 2017 00:15:00 -0400 https://www.proactiveinvestors.com/companies/news/183196/admedus-beats-revenue-forecasts-for-financial-year-2017-183196.html Admedus Ltd readies commercial CardioCel® 3D launch https://www.proactiveinvestors.com/companies/news/180501/admedus-ltd-readies-commercial-cardiocel-3d-launch-180501.html Fri, 07 Jul 2017 04:00:00 -0400 https://www.proactiveinvestors.com/companies/news/180501/admedus-ltd-readies-commercial-cardiocel-3d-launch-180501.html Admedus' Wayne Paterson discusses revenue strategy and pathway for CardioCel 3D https://www.proactiveinvestors.com/companies/news/307646/admedus-wayne-paterson-discusses-revenue-strategy-and-pathway-for-cardiocel-3d-7646.html Sun, 18 Jun 2017 22:00:00 -0400 https://www.proactiveinvestors.com/companies/news/307646/admedus-wayne-paterson-discusses-revenue-strategy-and-pathway-for-cardiocel-3d-7646.html Admedus appoints new chief operating officer https://www.proactiveinvestors.com/companies/news/179002/admedus-appoints-new-chief-operating-officer-179002.html Fri, 09 Jun 2017 01:00:00 -0400 https://www.proactiveinvestors.com/companies/news/179002/admedus-appoints-new-chief-operating-officer-179002.html Admedus meets primary endpoint for herpes vaccine study https://www.proactiveinvestors.com/companies/news/177275/admedus-meets-primary-endpoint-for-herpes-vaccine-study-177275.html Thu, 04 May 2017 03:00:00 -0400 https://www.proactiveinvestors.com/companies/news/177275/admedus-meets-primary-endpoint-for-herpes-vaccine-study-177275.html Admedus shares open higher on FDA clearance for CardioCel 3D https://www.proactiveinvestors.com/companies/news/177116/admedus-shares-open-higher-on-fda-clearance-for-cardiocel-3d-177116.html Tue, 02 May 2017 00:30:00 -0400 https://www.proactiveinvestors.com/companies/news/177116/admedus-shares-open-higher-on-fda-clearance-for-cardiocel-3d-177116.html Admedus grows cash balance over March quarter https://www.proactiveinvestors.com/companies/news/176956/admedus-grows-cash-balance-over-march-quarter-176956.html Wed, 26 Apr 2017 23:00:00 -0400 https://www.proactiveinvestors.com/companies/news/176956/admedus-grows-cash-balance-over-march-quarter-176956.html Admedus rewards Paterson with CEO appointment https://www.proactiveinvestors.com/companies/news/174803/admedus-rewards-paterson-with-ceo-appointment-174803.html Wed, 15 Mar 2017 00:00:00 -0400 https://www.proactiveinvestors.com/companies/news/174803/admedus-rewards-paterson-with-ceo-appointment-174803.html Admedus appoints John Seaberg as chairman https://www.proactiveinvestors.com/companies/news/174718/admedus-appoints-john-seaberg-as-chairman-174718.html Mon, 13 Mar 2017 22:00:00 -0400 https://www.proactiveinvestors.com/companies/news/174718/admedus-appoints-john-seaberg-as-chairman-174718.html Admedus receives a Buy Recommendation from Patersons https://www.proactiveinvestors.com/companies/news/174501/admedus-receives-a-buy-recommendation-from-patersons-174501.html Wed, 08 Mar 2017 23:00:00 -0500 https://www.proactiveinvestors.com/companies/news/174501/admedus-receives-a-buy-recommendation-from-patersons-174501.html Admedus receives approval to sell CardioCel® in Saudi Arabia https://www.proactiveinvestors.com/companies/news/173957/admedus-receives-approval-to-sell-cardiocel-in-saudi-arabia-173957.html Tue, 28 Feb 2017 22:00:00 -0500 https://www.proactiveinvestors.com/companies/news/173957/admedus-receives-approval-to-sell-cardiocel-in-saudi-arabia-173957.html Admedus reports strong sales growth in December half https://www.proactiveinvestors.com/companies/news/173746/admedus-reports-strong-sales-growth-in-december-half-173746.html Sun, 26 Feb 2017 21:00:00 -0500 https://www.proactiveinvestors.com/companies/news/173746/admedus-reports-strong-sales-growth-in-december-half-173746.html Admedus appoints Simon Buckingham to board https://www.proactiveinvestors.com/companies/news/173291/admedus-appoints-simon-buckingham-to-board-173291.html Thu, 16 Feb 2017 22:30:00 -0500 https://www.proactiveinvestors.com/companies/news/173291/admedus-appoints-simon-buckingham-to-board-173291.html Admedus finishes year with growing revenue after successful restructure https://www.proactiveinvestors.com/companies/news/170907/admedus-finishes-year-with-growing-revenue-after-successful-restructure-170907.html Thu, 22 Dec 2016 23:30:00 -0500 https://www.proactiveinvestors.com/companies/news/170907/admedus-finishes-year-with-growing-revenue-after-successful-restructure-170907.html Admedus Ltd to drive growth with market expansion of CardioCel® sales https://www.proactiveinvestors.com/companies/news/169227/admedus-ltd-to-drive-growth-with-market-expansion-of-cardiocel-sales-169227.html Mon, 21 Nov 2016 01:00:00 -0500 https://www.proactiveinvestors.com/companies/news/169227/admedus-ltd-to-drive-growth-with-market-expansion-of-cardiocel-sales-169227.html Admedus Ltd continues to kick goals, quarterly revenue up 50% https://www.proactiveinvestors.com/companies/news/168183/admedus-ltd-continues-to-kick-goals-quarterly-revenue-up-50-168183.html Fri, 28 Oct 2016 02:00:00 -0400 https://www.proactiveinvestors.com/companies/news/168183/admedus-ltd-continues-to-kick-goals-quarterly-revenue-up-50-168183.html Admedus Ltd receives some more positive results from HSV-2 study https://www.proactiveinvestors.com/companies/news/167602/admedus-ltd-receives-some-more-positive-results-from-hsv-2-study-167602.html Fri, 21 Oct 2016 03:00:00 -0400 https://www.proactiveinvestors.com/companies/news/167602/admedus-ltd-receives-some-more-positive-results-from-hsv-2-study-167602.html Admedus Ltd gets FDA clearance to launch VascuCel in the U.S. https://www.proactiveinvestors.com/companies/news/167459/admedus-ltd-gets-fda-clearance-to-launch-vascucel-in-the-us-167459.html Mon, 17 Oct 2016 01:00:00 -0400 https://www.proactiveinvestors.com/companies/news/167459/admedus-ltd-gets-fda-clearance-to-launch-vascucel-in-the-us-167459.html Admedus makes key appointment https://www.proactiveinvestors.com/companies/news/167249/admedus-makes-key-appointment-167249.html Tue, 11 Oct 2016 22:00:00 -0400 https://www.proactiveinvestors.com/companies/news/167249/admedus-makes-key-appointment-167249.html Admedus Ltd's new appointments strengthen revenue generation focus https://www.proactiveinvestors.com/companies/news/166414/admedus-ltds-new-appointments-strengthen-revenue-generation-focus-71204.html Mon, 26 Sep 2016 01:00:00 -0400 https://www.proactiveinvestors.com/companies/news/166414/admedus-ltds-new-appointments-strengthen-revenue-generation-focus-71204.html Admedus Ltd announces settlement of Federal Court proceedings https://www.proactiveinvestors.com/companies/news/165505/admedus-ltd-announces-settlement-of-federal-court-proceedings-70941.html Thu, 08 Sep 2016 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/165505/admedus-ltd-announces-settlement-of-federal-court-proceedings-70941.html Admedus Ltd finishes off $18.3M raising to fund growth https://www.proactiveinvestors.com/companies/news/165504/admedus-ltd-finishes-off-183m-raising-to-fund-growth-70783.html Wed, 31 Aug 2016 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/165504/admedus-ltd-finishes-off-183m-raising-to-fund-growth-70783.html Admedus Ltd appoints new CFO as part of move to Brisbane https://www.proactiveinvestors.com/companies/news/165503/admedus-ltd-appoints-new-cfo-as-part-of-move-to-brisbane-70685.html Fri, 26 Aug 2016 00:00:00 -0400 https://www.proactiveinvestors.com/companies/news/165503/admedus-ltd-appoints-new-cfo-as-part-of-move-to-brisbane-70685.html Admedus Ltd opens rights issue to support strong growth https://www.proactiveinvestors.com/companies/news/165502/admedus-ltd-opens-rights-issue-to-support-strong-growth-70527.html Thu, 18 Aug 2016 00:00:00 -0400 https://www.proactiveinvestors.com/companies/news/165502/admedus-ltd-opens-rights-issue-to-support-strong-growth-70527.html Admedus Ltd pockets A$10M from oversubscribed placement https://www.proactiveinvestors.com/companies/news/148026/admedus-ltd-pockets-a10m-from-oversubscribed-placement-70121.html Thu, 28 Jul 2016 23:40:00 -0400 https://www.proactiveinvestors.com/companies/news/148026/admedus-ltd-pockets-a10m-from-oversubscribed-placement-70121.html Admedus Ltd to outline capital raising https://www.proactiveinvestors.com/companies/news/148025/admedus-ltd-to-outline-capital-raising-70058.html Wed, 27 Jul 2016 02:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148025/admedus-ltd-to-outline-capital-raising-70058.html Admedus Ltd grows FY16 sales by 40% as future forecasts accelerate https://www.proactiveinvestors.com/companies/news/148024/admedus-ltd-grows-fy16-sales-by-40-as-future-forecasts-accelerate-69927.html Wed, 20 Jul 2016 02:00:00 -0400 https://www.proactiveinvestors.com/companies/news/148024/admedus-ltd-grows-fy16-sales-by-40-as-future-forecasts-accelerate-69927.html Admedus Ltd: New York's Maxim Group maintains A$2.00 price target https://www.proactiveinvestors.com/companies/news/148023/admedus-ltd-new-yorks-maxim-group-maintains-a200-price-target-69766.html Tue, 12 Jul 2016 22:00:00 -0400 https://www.proactiveinvestors.com/companies/news/148023/admedus-ltd-new-yorks-maxim-group-maintains-a200-price-target-69766.html Admedus Ltd receives Buy recommendation from New York firm https://www.proactiveinvestors.com/companies/news/148022/admedus-ltd-receives-buy-recommendation-from-new-york-firm-69126.html Thu, 09 Jun 2016 00:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148022/admedus-ltd-receives-buy-recommendation-from-new-york-firm-69126.html Admedus Ltd undertakes review of operations https://www.proactiveinvestors.com/companies/news/148021/admedus-ltd-undertakes-review-of-operations-69086.html Tue, 07 Jun 2016 07:00:00 -0400 https://www.proactiveinvestors.com/companies/news/148021/admedus-ltd-undertakes-review-of-operations-69086.html Admedus Ltd appoints Mathew Ratty to the board https://www.proactiveinvestors.com/companies/news/148020/admedus-ltd-appoints-mathew-ratty-to-the-board-68867.html Fri, 27 May 2016 00:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148020/admedus-ltd-appoints-mathew-ratty-to-the-board-68867.html Admedus Ltd awarded major supply contract with Royal Adelaide Hospital https://www.proactiveinvestors.com/companies/news/148019/admedus-ltd-awarded-major-supply-contract-with-royal-adelaide-hospital-68810.html Tue, 24 May 2016 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148019/admedus-ltd-awarded-major-supply-contract-with-royal-adelaide-hospital-68810.html Admedus Ltd outlines board changes https://www.proactiveinvestors.com/companies/news/148018/admedus-ltd-outlines-board-changes-68754.html Mon, 23 May 2016 22:00:00 -0400 https://www.proactiveinvestors.com/companies/news/148018/admedus-ltd-outlines-board-changes-68754.html Admedus Ltd wins the peer voted ‘Manufacturer of the Year’ award https://www.proactiveinvestors.com/companies/news/148017/admedus-ltd-wins-the-peer-voted-manufacturer-of-the-year-award-68592.html Thu, 12 May 2016 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148017/admedus-ltd-wins-the-peer-voted-manufacturer-of-the-year-award-68592.html Admedus Ltd to showcase CardioCel® in the U.S. to drive sales https://www.proactiveinvestors.com/companies/news/148016/admedus-ltd-to-showcase-cardiocel-in-the-us-to-drive-sales-68571.html Wed, 11 May 2016 23:00:00 -0400 https://www.proactiveinvestors.com/companies/news/148016/admedus-ltd-to-showcase-cardiocel-in-the-us-to-drive-sales-68571.html Admedus Ltd posts 73% increase in March quarter sales https://www.proactiveinvestors.com/companies/news/148015/admedus-ltd-posts-73-increase-in-march-quarter-sales-68349.html Thu, 28 Apr 2016 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148015/admedus-ltd-posts-73-increase-in-march-quarter-sales-68349.html Admedus Ltd expands distribution agreement with CORONEO https://www.proactiveinvestors.com/companies/news/148014/admedus-ltd-expands-distribution-agreement-with-coroneo-67962.html Fri, 08 Apr 2016 00:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148014/admedus-ltd-expands-distribution-agreement-with-coroneo-67962.html Admedus Ltd demonstrates close profile to native aortic valve https://www.proactiveinvestors.com/companies/news/148013/admedus-ltd-demonstrates-close-profile-to-native-aortic-valve-67730.html Mon, 28 Mar 2016 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148013/admedus-ltd-demonstrates-close-profile-to-native-aortic-valve-67730.html Admedus Ltd receives $2.00 price target from New York based Maxim Group https://www.proactiveinvestors.com/companies/news/148012/admedus-ltd-receives-200-price-target-from-new-york-based-maxim-group-67475.html Sun, 13 Mar 2016 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/148012/admedus-ltd-receives-200-price-target-from-new-york-based-maxim-group-67475.html Admedus Ltd receives A$1.95 valuation from Hong Kong firm https://www.proactiveinvestors.com/companies/news/148011/admedus-ltd-receives-a195-valuation-from-hong-kong-firm-67432.html Wed, 09 Mar 2016 23:30:00 -0500 https://www.proactiveinvestors.com/companies/news/148011/admedus-ltd-receives-a195-valuation-from-hong-kong-firm-67432.html Admedus Ltd chairman acquires shares on market https://www.proactiveinvestors.com/companies/news/148010/admedus-ltd-chairman-acquires-shares-on-market-67416.html Wed, 09 Mar 2016 06:40:00 -0500 https://www.proactiveinvestors.com/companies/news/148010/admedus-ltd-chairman-acquires-shares-on-market-67416.html Admedus COO encouraged by initial results from Phase II herpes vaccine trial https://www.proactiveinvestors.com/companies/news/304740/admedus-coo-encouraged-by-initial-results-from-phase-ii-herpes-vaccine-trial-4740.html Tue, 08 Mar 2016 12:55:00 -0500 https://www.proactiveinvestors.com/companies/news/304740/admedus-coo-encouraged-by-initial-results-from-phase-ii-herpes-vaccine-trial-4740.html Admedus Ltd's COO Julian Chick talks to Proactive Investors on interim Herpes Simplex Virus Phase II clinical trial data https://www.proactiveinvestors.com/companies/news/305585/admedus-ltds-coo-julian-chick-talks-to-proactive-investors-on-interim-herpes-simplex-virus-phase-ii-clinical-trial-data-577.html Mon, 07 Mar 2016 22:30:00 -0500 https://www.proactiveinvestors.com/companies/news/305585/admedus-ltds-coo-julian-chick-talks-to-proactive-investors-on-interim-herpes-simplex-virus-phase-ii-clinical-trial-data-577.html Admedus has encouraging results from Phase II herpes simplex trial https://www.proactiveinvestors.com/companies/news/148009/admedus-has-encouraging-results-from-phase-ii-herpes-simplex-trial-67335.html Thu, 03 Mar 2016 23:00:00 -0500 https://www.proactiveinvestors.com/companies/news/148009/admedus-has-encouraging-results-from-phase-ii-herpes-simplex-trial-67335.html Admedus delivers strong revenue growth on CardioCel® roll-out https://www.proactiveinvestors.com/companies/news/148008/admedus-delivers-strong-revenue-growth-on-cardiocel-roll-out-67217.html Thu, 25 Feb 2016 23:00:00 -0500 https://www.proactiveinvestors.com/companies/news/148008/admedus-delivers-strong-revenue-growth-on-cardiocel-roll-out-67217.html Admedus awaits Herpes Simplex Virus phase 2 clinical study results https://www.proactiveinvestors.com/companies/news/148007/admedus-awaits-herpes-simplex-virus-phase-2-clinical-study-results-67011.html Mon, 15 Feb 2016 00:30:00 -0500 https://www.proactiveinvestors.com/companies/news/148007/admedus-awaits-herpes-simplex-virus-phase-2-clinical-study-results-67011.html Admedus Limited appoints Wayne Paterson as chairman https://www.proactiveinvestors.com/companies/news/148006/admedus-limited-appoints-wayne-paterson-as-chairman-66948.html Wed, 10 Feb 2016 04:00:00 -0500 https://www.proactiveinvestors.com/companies/news/148006/admedus-limited-appoints-wayne-paterson-as-chairman-66948.html Admedus to add revenue as heart disease tech distribution grows https://www.proactiveinvestors.com/companies/news/148005/admedus-to-add-revenue-as-heart-disease-tech-distribution-grows-66722.html Wed, 27 Jan 2016 01:41:00 -0500 https://www.proactiveinvestors.com/companies/news/148005/admedus-to-add-revenue-as-heart-disease-tech-distribution-grows-66722.html Admedus receives notice of initial substantial holder from Sabby Management https://www.proactiveinvestors.com/companies/news/148004/admedus-receives-notice-of-initial-substantial-holder-from-sabby-management-66364.html Tue, 29 Dec 2015 02:00:00 -0500 https://www.proactiveinvestors.com/companies/news/148004/admedus-receives-notice-of-initial-substantial-holder-from-sabby-management-66364.html Admedus finishes 2015 in strong position after achieving milestones https://www.proactiveinvestors.com/companies/news/148003/admedus-finishes-2015-in-strong-position-after-achieving-milestones-66357.html Wed, 23 Dec 2015 23:00:00 -0500 https://www.proactiveinvestors.com/companies/news/148003/admedus-finishes-2015-in-strong-position-after-achieving-milestones-66357.html Admedus attracts U.S. investors in private placement https://www.proactiveinvestors.com/companies/news/148002/admedus-attracts-us-investors-in-private-placement-66313.html Mon, 21 Dec 2015 23:30:00 -0500 https://www.proactiveinvestors.com/companies/news/148002/admedus-attracts-us-investors-in-private-placement-66313.html Admedus Limited sets sail for raising https://www.proactiveinvestors.com/companies/news/148001/admedus-limited-sets-sail-for-raising-66252.html Fri, 18 Dec 2015 01:00:00 -0500 https://www.proactiveinvestors.com/companies/news/148001/admedus-limited-sets-sail-for-raising-66252.html Admedus pumping along: broker report https://www.proactiveinvestors.com/companies/news/148000/admedus-pumping-along-broker-report-65588.html Fri, 13 Nov 2015 02:30:00 -0500 https://www.proactiveinvestors.com/companies/news/148000/admedus-pumping-along-broker-report-65588.html Admedus taps huge European market with green light for CardioCel https://www.proactiveinvestors.com/companies/news/147999/admedus-taps-huge-european-market-with-green-light-for-cardiocel-65482.html Mon, 09 Nov 2015 00:00:00 -0500 https://www.proactiveinvestors.com/companies/news/147999/admedus-taps-huge-european-market-with-green-light-for-cardiocel-65482.html Admedus to add revenue as global CardioCel rollout enters Malaysia https://www.proactiveinvestors.com/companies/news/147998/admedus-to-add-revenue-as-global-cardiocel-rollout-enters-malaysia-65423.html Wed, 04 Nov 2015 00:10:00 -0500 https://www.proactiveinvestors.com/companies/news/147998/admedus-to-add-revenue-as-global-cardiocel-rollout-enters-malaysia-65423.html Admedus Limited underlines viability of expanding heart surgery method https://www.proactiveinvestors.com/companies/news/147997/admedus-limited-underlines-viability-of-expanding-heart-surgery-method-64935.html Tue, 06 Oct 2015 01:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147997/admedus-limited-underlines-viability-of-expanding-heart-surgery-method-64935.html Admedus and Ear Science Institute Australia team up on stem cell delivery https://www.proactiveinvestors.com/companies/news/147996/admedus-and-ear-science-institute-australia-team-up-on-stem-cell-delivery-64840.html Wed, 30 Sep 2015 03:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147996/admedus-and-ear-science-institute-australia-team-up-on-stem-cell-delivery-64840.html Admedus starts heart valve clinical study https://www.proactiveinvestors.com/companies/news/147995/admedus-starts-heart-valve-clinical-study-64695.html Wed, 23 Sep 2015 00:06:00 -0400 https://www.proactiveinvestors.com/companies/news/147995/admedus-starts-heart-valve-clinical-study-64695.html Admedus develops new CardioCel product for repair of heart defects https://www.proactiveinvestors.com/companies/news/147994/admedus-develops-new-cardiocel-product-for-repair-of-heart-defects-64347.html Wed, 02 Sep 2015 23:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147994/admedus-develops-new-cardiocel-product-for-repair-of-heart-defects-64347.html Admedus receives $0.18 price target from broker https://www.proactiveinvestors.com/companies/news/147993/admedus-receives-018-price-target-from-broker-64282.html Mon, 31 Aug 2015 22:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147993/admedus-receives-018-price-target-from-broker-64282.html Admedus' herpes therapeutic vaccine study gains safety nod https://www.proactiveinvestors.com/companies/news/147992/admedus-herpes-therapeutic-vaccine-study-gains-safety-nod-64220.html Wed, 26 Aug 2015 23:14:00 -0400 https://www.proactiveinvestors.com/companies/news/147992/admedus-herpes-therapeutic-vaccine-study-gains-safety-nod-64220.html Admedus rapid revenue growth driven by global sales success https://www.proactiveinvestors.com/companies/news/147991/admedus-rapid-revenue-growth-driven-by-global-sales-success-63741.html Thu, 30 Jul 2015 04:07:00 -0400 https://www.proactiveinvestors.com/companies/news/147991/admedus-rapid-revenue-growth-driven-by-global-sales-success-63741.html Admedus’ CardioCel has long term potential for congenital heart disease https://www.proactiveinvestors.com/companies/news/147990/admedus-cardiocel-has-long-term-potential-for-congenital-heart-disease-63342.html Tue, 07 Jul 2015 23:08:00 -0400 https://www.proactiveinvestors.com/companies/news/147990/admedus-cardiocel-has-long-term-potential-for-congenital-heart-disease-63342.html Admedus' CardioCel cardiovascular used in 80 treatment centres https://www.proactiveinvestors.com/companies/news/147989/admedus-cardiocel-cardiovascular-used-in-80-treatment-centres-62992.html Wed, 17 Jun 2015 23:40:00 -0400 https://www.proactiveinvestors.com/companies/news/147989/admedus-cardiocel-cardiovascular-used-in-80-treatment-centres-62992.html Admedus moves to second dose of Herpes vaccine https://www.proactiveinvestors.com/companies/news/147988/admedus-moves-to-second-dose-of-herpes-vaccine-62766.html Thu, 04 Jun 2015 22:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147988/admedus-moves-to-second-dose-of-herpes-vaccine-62766.html Admedus Limited launches new CardioCel product for vascular repair https://www.proactiveinvestors.com/companies/news/147987/admedus-limited-launches-new-cardiocel-product-for-vascular-repair-62410.html Sun, 17 May 2015 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147987/admedus-limited-launches-new-cardiocel-product-for-vascular-repair-62410.html Admedus directors increase shareholdings https://www.proactiveinvestors.com/companies/news/147986/admedus-directors-increase-shareholdings-61942.html Fri, 24 Apr 2015 00:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147986/admedus-directors-increase-shareholdings-61942.html Admedus appoints Genpharm as Middle East, North Africa distributor https://www.proactiveinvestors.com/companies/news/147985/admedus-appoints-genpharm-as-middle-east-north-africa-distributor-61902.html Tue, 21 Apr 2015 22:40:00 -0400 https://www.proactiveinvestors.com/companies/news/147985/admedus-appoints-genpharm-as-middle-east-north-africa-distributor-61902.html Admedus receives A$0.20 price target from Morgans https://www.proactiveinvestors.com/companies/news/147984/admedus-receives-a020-price-target-from-morgans-61856.html Mon, 20 Apr 2015 21:10:00 -0400 https://www.proactiveinvestors.com/companies/news/147984/admedus-receives-a020-price-target-from-morgans-61856.html Admedus Limited with $28M funding to grow global healthcare business https://www.proactiveinvestors.com/companies/news/147983/admedus-limited-with-28m-funding-to-grow-global-healthcare-business-61829.html Fri, 17 Apr 2015 02:53:00 -0400 https://www.proactiveinvestors.com/companies/news/147983/admedus-limited-with-28m-funding-to-grow-global-healthcare-business-61829.html Admedus has high hopes for Herpes vaccine as dosing commences https://www.proactiveinvestors.com/companies/news/147982/admedus-has-high-hopes-for-herpes-vaccine-as-dosing-commences-61686.html Thu, 09 Apr 2015 22:01:00 -0400 https://www.proactiveinvestors.com/companies/news/147982/admedus-has-high-hopes-for-herpes-vaccine-as-dosing-commences-61686.html Admedus Limited expands market for ADAPT® tissue products https://www.proactiveinvestors.com/companies/news/147981/admedus-limited-expands-market-for-adapt-tissue-products-61610.html Mon, 06 Apr 2015 23:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147981/admedus-limited-expands-market-for-adapt-tissue-products-61610.html Admedus Limited raising up to $16.1M to advance business opportunities https://www.proactiveinvestors.com/companies/news/147980/admedus-limited-raising-up-to-161m-to-advance-business-opportunities-61526.html Tue, 31 Mar 2015 01:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147980/admedus-limited-raising-up-to-161m-to-advance-business-opportunities-61526.html Admedus Limited non-executive director exercises options https://www.proactiveinvestors.com/companies/news/147979/admedus-limited-non-executive-director-exercises-options-61480.html Fri, 27 Mar 2015 04:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147979/admedus-limited-non-executive-director-exercises-options-61480.html Admedus clinches $12M in oversubscribed placement https://www.proactiveinvestors.com/companies/news/147978/admedus-clinches-12m-in-oversubscribed-placement--61307.html Tue, 17 Mar 2015 23:22:00 -0400 https://www.proactiveinvestors.com/companies/news/147978/admedus-clinches-12m-in-oversubscribed-placement--61307.html Admedus heads to market, granted trading halt https://www.proactiveinvestors.com/companies/news/147977/admedus-heads-to-market-granted-trading-halt-61258.html Mon, 16 Mar 2015 01:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147977/admedus-heads-to-market-granted-trading-halt-61258.html Admedus expands CardioCel® market, anticipates record sales https://www.proactiveinvestors.com/companies/news/147976/admedus-expands-cardiocel-market-anticipates-record-sales-61217.html Wed, 11 Mar 2015 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147976/admedus-expands-cardiocel-market-anticipates-record-sales-61217.html Admedus receives A$0.22 price target from Morgans https://www.proactiveinvestors.com/companies/news/147975/admedus-receives-a022-price-target-from-morgans-61029.html Tue, 03 Mar 2015 02:05:00 -0500 https://www.proactiveinvestors.com/companies/news/147975/admedus-receives-a022-price-target-from-morgans-61029.html Admedus: CardioCel® sales growth drives revenue higher https://www.proactiveinvestors.com/companies/news/147974/admedus-cardiocel-sales-growth-drives-revenue-higher-60439.html Mon, 02 Feb 2015 00:00:00 -0500 https://www.proactiveinvestors.com/companies/news/147974/admedus-cardiocel-sales-growth-drives-revenue-higher-60439.html Admedus Limited's CardioCel® broadens market applications https://www.proactiveinvestors.com/companies/news/147973/admedus-limiteds-cardiocel-broadens-market-applications-59885.html Mon, 05 Jan 2015 02:30:00 -0500 https://www.proactiveinvestors.com/companies/news/147973/admedus-limiteds-cardiocel-broadens-market-applications-59885.html Admedus Limited's Herpes vaccine Phase II study receives ethics approval https://www.proactiveinvestors.com/companies/news/147972/admedus-limiteds-herpes-vaccine-phase-ii-study-receives-ethics-approval-59776.html Wed, 24 Dec 2014 00:16:00 -0500 https://www.proactiveinvestors.com/companies/news/147972/admedus-limiteds-herpes-vaccine-phase-ii-study-receives-ethics-approval-59776.html Admedus on track to becoming an integrated healthcare company https://www.proactiveinvestors.com/companies/news/147971/admedus-on-track-to-becoming-an-integrated-healthcare-company-59325.html Tue, 02 Dec 2014 23:00:00 -0500 https://www.proactiveinvestors.com/companies/news/147971/admedus-on-track-to-becoming-an-integrated-healthcare-company-59325.html Admedus finds success in Human Papilloma Virus vaccine studies https://www.proactiveinvestors.com/companies/news/147970/admedus-finds-success-in-human-papilloma-virus-vaccine-studies-59138.html Sun, 23 Nov 2014 23:05:00 -0500 https://www.proactiveinvestors.com/companies/news/147970/admedus-finds-success-in-human-papilloma-virus-vaccine-studies-59138.html Admedus substantial shareholder increases interest to 6.2% https://www.proactiveinvestors.com/companies/news/147968/admedus-substantial-shareholder-increases-interest-to-62-58815.html Mon, 10 Nov 2014 03:30:00 -0500 https://www.proactiveinvestors.com/companies/news/147968/admedus-substantial-shareholder-increases-interest-to-62-58815.html Admedus CardioCel® gains approval in Singapore https://www.proactiveinvestors.com/companies/news/147967/admedus-cardiocel-gains-approval-in-singapore-58634.html Sun, 02 Nov 2014 23:20:00 -0500 https://www.proactiveinvestors.com/companies/news/147967/admedus-cardiocel-gains-approval-in-singapore-58634.html Admedus Limited to launch CardioCel® medical device in Canada https://www.proactiveinvestors.com/companies/news/147966/admedus-limited-to-launch-cardiocel-medical-device-in-canada-58290.html Sun, 19 Oct 2014 23:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147966/admedus-limited-to-launch-cardiocel-medical-device-in-canada-58290.html Admedus appoints John Seaberg and Wayne Paterson to the board https://www.proactiveinvestors.com/companies/news/147965/admedus-appoints-john-seaberg-and-wayne-paterson-to-the-board-58089.html Fri, 10 Oct 2014 01:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147965/admedus-appoints-john-seaberg-and-wayne-paterson-to-the-board-58089.html Admedus vaccine for herpes has success; moves to next clinical trial https://www.proactiveinvestors.com/companies/news/147964/admedus-vaccine-for-herpes-has-success-moves-to-next-clinical-trial-57916.html Wed, 01 Oct 2014 22:59:00 -0400 https://www.proactiveinvestors.com/companies/news/147964/admedus-vaccine-for-herpes-has-success-moves-to-next-clinical-trial-57916.html Admedus receives notice of initial substantial shareholder https://www.proactiveinvestors.com/companies/news/147963/admedus-receives-notice-of-initial-substantial-shareholder-57881.html Tue, 30 Sep 2014 06:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147963/admedus-receives-notice-of-initial-substantial-shareholder-57881.html Admedus revenue up 7.09% for FY2014 https://www.proactiveinvestors.com/companies/news/147962/admedus-revenue-up-709-for-fy2014-57226.html Thu, 28 Aug 2014 06:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147962/admedus-revenue-up-709-for-fy2014-57226.html Admedus starts shipping CardioCel® to the U.S. from WA facility https://www.proactiveinvestors.com/companies/news/147961/admedus-starts-shipping-cardiocel-to-the-us-from-wa-facility-56915.html Wed, 13 Aug 2014 23:50:00 -0400 https://www.proactiveinvestors.com/companies/news/147961/admedus-starts-shipping-cardiocel-to-the-us-from-wa-facility-56915.html Admedus delivers more stellar results https://www.proactiveinvestors.com/companies/news/147960/admedus-delivers-more-stellar-results-56602.html Wed, 30 Jul 2014 03:26:00 -0400 https://www.proactiveinvestors.com/companies/news/147960/admedus-delivers-more-stellar-results-56602.html Admedus increases interest in Prof Ian Frazer’s vaccines https://www.proactiveinvestors.com/companies/news/147959/admedus-increases-interest-in-prof-ian-frazers-vaccines-56472.html Wed, 23 Jul 2014 23:23:00 -0400 https://www.proactiveinvestors.com/companies/news/147959/admedus-increases-interest-in-prof-ian-frazers-vaccines-56472.html Admedus expects $9M income for financial year https://www.proactiveinvestors.com/companies/news/147958/admedus-expects-9m-income-for-financial-year-55867.html Wed, 25 Jun 2014 23:25:00 -0400 https://www.proactiveinvestors.com/companies/news/147958/admedus-expects-9m-income-for-financial-year-55867.html Admedus raises $10.1M in SPP after strong investor support https://www.proactiveinvestors.com/companies/news/147957/admedus-raises-101m-in-spp-after-strong-investor-support-55489.html Fri, 06 Jun 2014 07:24:00 -0400 https://www.proactiveinvestors.com/companies/news/147957/admedus-raises-101m-in-spp-after-strong-investor-support-55489.html Admedus' SPP funds to enhance growth in 2014 https://www.proactiveinvestors.com/companies/news/147956/admedus-spp-funds-to-enhance-growth-in-2014-55056.html Mon, 19 May 2014 05:23:00 -0400 https://www.proactiveinvestors.com/companies/news/147956/admedus-spp-funds-to-enhance-growth-in-2014-55056.html Admedus has further growth in sights following $8M placement https://www.proactiveinvestors.com/companies/news/147955/admedus-has-further-growth-in-sights-following-8m-placement-54864.html Sun, 11 May 2014 23:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147955/admedus-has-further-growth-in-sights-following-8m-placement-54864.html Admedus to raise capital https://www.proactiveinvestors.com/companies/news/147954/admedus-to-raise-capital-54798.html Thu, 08 May 2014 00:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147954/admedus-to-raise-capital-54798.html Admedus in maiden sale of CardioCel® in U.S.A. https://www.proactiveinvestors.com/companies/news/147953/admedus-in-maiden-sale-of-cardiocel-in-usa-54775.html Wed, 07 May 2014 00:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147953/admedus-in-maiden-sale-of-cardiocel-in-usa-54775.html Admedus' CardioCel® shows promise to treat congenital heart disease https://www.proactiveinvestors.com/companies/news/147952/admedus-cardiocel-shows-promise-to-treat-congenital-heart-disease-54635.html Thu, 01 May 2014 00:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147952/admedus-cardiocel-shows-promise-to-treat-congenital-heart-disease-54635.html Admedus receives Buy and $0.25 target from Australian broker https://www.proactiveinvestors.com/companies/news/147951/admedus-receives-buy-and-025-target-from-australian-broker-54105.html Thu, 03 Apr 2014 23:51:00 -0400 https://www.proactiveinvestors.com/companies/news/147951/admedus-receives-buy-and-025-target-from-australian-broker-54105.html Admedus receives key FDA clearance to sell CardioCel® in the U.S. https://www.proactiveinvestors.com/companies/news/147950/admedus-receives-key-fda-clearance-to-sell-cardiocel-in-the-us-52655.html Mon, 10 Feb 2014 00:06:00 -0500 https://www.proactiveinvestors.com/companies/news/147950/admedus-receives-key-fda-clearance-to-sell-cardiocel-in-the-us-52655.html Admedus herpes vaccine proven safe in Phase 1 trial subjects https://www.proactiveinvestors.com/companies/news/147949/admedus-herpes-vaccine-proven-safe-in-phase-1-trial-subjects-52421.html Sun, 02 Feb 2014 23:25:00 -0500 https://www.proactiveinvestors.com/companies/news/147949/admedus-herpes-vaccine-proven-safe-in-phase-1-trial-subjects-52421.html Admedus completes acquisition of WA manufacturing site for CardioCel® https://www.proactiveinvestors.com/companies/news/147948/admedus-completes-acquisition-of-wa-manufacturing-site-for-cardiocel-51557.html Thu, 02 Jan 2014 23:30:00 -0500 https://www.proactiveinvestors.com/companies/news/147948/admedus-completes-acquisition-of-wa-manufacturing-site-for-cardiocel-51557.html Admedus looks to build global healthcare business https://www.proactiveinvestors.com/companies/news/147947/admedus-looks-to-build-global-healthcare-business-51420.html Tue, 24 Dec 2013 01:40:00 -0500 https://www.proactiveinvestors.com/companies/news/147947/admedus-looks-to-build-global-healthcare-business-51420.html Admedus acquires WA manufacturing site for CardioCel® https://www.proactiveinvestors.com/companies/news/147946/admedus-acquires-wa-manufacturing-site-for-cardiocel-51105.html Wed, 11 Dec 2013 23:40:00 -0500 https://www.proactiveinvestors.com/companies/news/147946/admedus-acquires-wa-manufacturing-site-for-cardiocel-51105.html Admedus Limited, formerly Allied Healthcare name change effective today https://www.proactiveinvestors.com/companies/news/147945/admedus-limited-formerly-allied-healthcare-name-change-effective-today-50500.html Mon, 25 Nov 2013 02:00:00 -0500 https://www.proactiveinvestors.com/companies/news/147945/admedus-limited-formerly-allied-healthcare-name-change-effective-today-50500.html Allied Healthcare Group changes name to Admedus Limited https://www.proactiveinvestors.com/companies/news/147944/allied-healthcare-group-changes-name-to-admedus-limited-50443.html Thu, 21 Nov 2013 08:00:00 -0500 https://www.proactiveinvestors.com/companies/news/147944/allied-healthcare-group-changes-name-to-admedus-limited-50443.html Allied Healthcare makes milestone sale of CardioCel® in Europe https://www.proactiveinvestors.com/companies/news/147943/allied-healthcare-makes-milestone-sale-of-cardiocel-in-europe-49984.html Thu, 07 Nov 2013 23:48:00 -0500 https://www.proactiveinvestors.com/companies/news/147943/allied-healthcare-makes-milestone-sale-of-cardiocel-in-europe-49984.html Allied Healthcare recognised as the biotech industry’s emerging company of the year https://www.proactiveinvestors.com/companies/news/147942/allied-healthcare-recognised-as-the-biotech-industrys-emerging-company-of-the-year-49693.html Thu, 31 Oct 2013 02:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147942/allied-healthcare-recognised-as-the-biotech-industrys-emerging-company-of-the-year-49693.html Allied Healthcare Group receives target share price of $0.20 from broker https://www.proactiveinvestors.com/companies/news/147941/allied-healthcare-group-receives-target-share-price-of-020-from-broker-49653.html Wed, 30 Oct 2013 07:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147941/allied-healthcare-group-receives-target-share-price-of-020-from-broker-49653.html Allied Healthcare shares re-rated 112% in the last two weeks https://www.proactiveinvestors.com/companies/news/147940/allied-healthcare-shares-re-rated-112-in-the-last-two-weeks-49605.html Tue, 29 Oct 2013 23:40:00 -0400 https://www.proactiveinvestors.com/companies/news/147940/allied-healthcare-shares-re-rated-112-in-the-last-two-weeks-49605.html Allied Healthcare directors increase shareholdings https://www.proactiveinvestors.com/companies/news/147939/allied-healthcare-directors-increase-shareholdings-49484.html Fri, 25 Oct 2013 00:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147939/allied-healthcare-directors-increase-shareholdings-49484.html Allied Healthcare closes $10.4M rights offer, oversubscribed https://www.proactiveinvestors.com/companies/news/147938/allied-healthcare-closes-104m-rights-offer-oversubscribed-49387.html Tue, 22 Oct 2013 23:41:00 -0400 https://www.proactiveinvestors.com/companies/news/147938/allied-healthcare-closes-104m-rights-offer-oversubscribed-49387.html Allied Healthcare’s herpes simplex vaccine trial under way https://www.proactiveinvestors.com/companies/news/147937/allied-healthcares-herpes-simplex-vaccine-trial-under-way-49190.html Wed, 16 Oct 2013 23:23:00 -0400 https://www.proactiveinvestors.com/companies/news/147937/allied-healthcares-herpes-simplex-vaccine-trial-under-way-49190.html Allied Healthcare Group’s CardioCel® adds additional surgeons approved for use https://www.proactiveinvestors.com/companies/news/147936/allied-healthcare-groups-cardiocel-adds-additional-surgeons-approved-for-use-48846.html Tue, 08 Oct 2013 00:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147936/allied-healthcare-groups-cardiocel-adds-additional-surgeons-approved-for-use-48846.html Allied Healthcare director exercises options https://www.proactiveinvestors.com/companies/news/147935/allied-healthcare-director-exercises-options--48555.html Fri, 27 Sep 2013 05:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147935/allied-healthcare-director-exercises-options--48555.html Allied Healthcare Group’s CardioCel® heart tissue patch shows no calcification after five years https://www.proactiveinvestors.com/companies/news/147934/allied-healthcare-groups-cardiocel-heart-tissue-patch-shows-no-calcification-after-five-years-48434.html Wed, 25 Sep 2013 01:40:00 -0400 https://www.proactiveinvestors.com/companies/news/147934/allied-healthcare-groups-cardiocel-heart-tissue-patch-shows-no-calcification-after-five-years-48434.html Allied Healthcare Group to raise $10M, fully underwritten issue https://www.proactiveinvestors.com/companies/news/147933/allied-healthcare-group-to-raise-10m-fully-underwritten-issue-48339.html Mon, 23 Sep 2013 00:44:00 -0400 https://www.proactiveinvestors.com/companies/news/147933/allied-healthcare-group-to-raise-10m-fully-underwritten-issue-48339.html Allied Healthcare Group and Prof Ian Frazer high hopes for genital herpes vaccine https://www.proactiveinvestors.com/companies/news/147932/allied-healthcare-group-and-prof-ian-frazer-high-hopes-for-genital-herpes-vaccine-47482.html Tue, 03 Sep 2013 02:01:00 -0400 https://www.proactiveinvestors.com/companies/news/147932/allied-healthcare-group-and-prof-ian-frazer-high-hopes-for-genital-herpes-vaccine-47482.html Allied Healthcare Group delivers strong revenue growth for FY13 https://www.proactiveinvestors.com/companies/news/147931/allied-healthcare-group-delivers-strong-revenue-growth-for-fy13-47399.html Fri, 30 Aug 2013 05:15:00 -0400 https://www.proactiveinvestors.com/companies/news/147931/allied-healthcare-group-delivers-strong-revenue-growth-for-fy13-47399.html Allied Healthcare secures CE Mark for CardioCel® regenerative tissue product https://www.proactiveinvestors.com/companies/news/147930/allied-healthcare-secures-ce-mark-for-cardiocel-regenerative-tissue-product-47148.html Sun, 25 Aug 2013 22:56:00 -0400 https://www.proactiveinvestors.com/companies/news/147930/allied-healthcare-secures-ce-mark-for-cardiocel-regenerative-tissue-product-47148.html Allied Healthcare jumps 31%, draws ASX price and volume query https://www.proactiveinvestors.com/companies/news/147929/allied-healthcare-jumps-31-draws-asx-price-and-volume-query-46935.html Tue, 20 Aug 2013 02:40:00 -0400 https://www.proactiveinvestors.com/companies/news/147929/allied-healthcare-jumps-31-draws-asx-price-and-volume-query-46935.html Allied Healthcare Group is 'pumping along': RBS Morgans https://www.proactiveinvestors.com/companies/news/147928/allied-healthcare-group-is-pumping-along-rbs-morgans-46723.html Wed, 14 Aug 2013 05:40:00 -0400 https://www.proactiveinvestors.com/companies/news/147928/allied-healthcare-group-is-pumping-along-rbs-morgans-46723.html Allied Healthcare 2013 financial year revenue up 15% https://www.proactiveinvestors.com/companies/news/147927/allied-healthcare-2013-financial-year-revenue-up-15--46136.html Tue, 30 Jul 2013 04:19:00 -0400 https://www.proactiveinvestors.com/companies/news/147927/allied-healthcare-2013-financial-year-revenue-up-15--46136.html Allied Healthcare substantial shareholder The Metal Group moves to 17.05% interest https://www.proactiveinvestors.com/companies/news/147926/allied-healthcare-substantial-shareholder-the-metal-group-moves-to-1705-interest-46129.html Tue, 30 Jul 2013 02:40:00 -0400 https://www.proactiveinvestors.com/companies/news/147926/allied-healthcare-substantial-shareholder-the-metal-group-moves-to-1705-interest-46129.html Allied Healthcare Group reports Queensland surgeon approved to use CardioCel® https://www.proactiveinvestors.com/companies/news/147925/allied-healthcare-group-reports-queensland-surgeon-approved-to-use-cardiocel-45285.html Sun, 07 Jul 2013 23:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147925/allied-healthcare-group-reports-queensland-surgeon-approved-to-use-cardiocel-45285.html Allied Healthcare Group ups stake in Prof Ian Frazer's Coridon https://www.proactiveinvestors.com/companies/news/147924/allied-healthcare-group-ups-stake-in-prof-ian-frazers-coridon-45015.html Mon, 01 Jul 2013 00:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147924/allied-healthcare-group-ups-stake-in-prof-ian-frazers-coridon-45015.html Allied Healthcare rated ‘outperform’ by RBS Morgans as big milestone looms https://www.proactiveinvestors.com/companies/news/147923/allied-healthcare-rated-outperform-by-rbs-morgans-as-big-milestone-looms-44808.html Mon, 24 Jun 2013 23:51:00 -0400 https://www.proactiveinvestors.com/companies/news/147923/allied-healthcare-rated-outperform-by-rbs-morgans-as-big-milestone-looms-44808.html Allied Healthcare to start landmark clinical trial for genital herpes vaccine https://www.proactiveinvestors.com/companies/news/147922/allied-healthcare-to-start-landmark-clinical-trial-for-genital-herpes-vaccine-44604.html Tue, 18 Jun 2013 23:46:00 -0400 https://www.proactiveinvestors.com/companies/news/147922/allied-healthcare-to-start-landmark-clinical-trial-for-genital-herpes-vaccine-44604.html Allied Healthcare receives $1.9M grant to commercialise heart tissue patch https://www.proactiveinvestors.com/companies/news/147921/allied-healthcare-receives-19m-grant-to-commercialise-heart-tissue-patch-44046.html Mon, 03 Jun 2013 02:41:00 -0400 https://www.proactiveinvestors.com/companies/news/147921/allied-healthcare-receives-19m-grant-to-commercialise-heart-tissue-patch-44046.html Allied Healthcare Group shares ride high on back of strong prospects for its CardioCel product https://www.proactiveinvestors.com/companies/news/147920/allied-healthcare-group-shares-ride-high-on-back-of-strong-prospects-for-its-cardiocel-product-43503.html Mon, 20 May 2013 07:05:00 -0400 https://www.proactiveinvestors.com/companies/news/147920/allied-healthcare-group-shares-ride-high-on-back-of-strong-prospects-for-its-cardiocel-product-43503.html Allied Healthcare Group on track for A$7M in sales for FY2013 https://www.proactiveinvestors.com/companies/news/147919/allied-healthcare-group-on-track-for-a7m-in-sales-for-fy2013-42567.html Mon, 29 Apr 2013 01:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147919/allied-healthcare-group-on-track-for-a7m-in-sales-for-fy2013-42567.html Allied Healthcare: More surgeons opt for early access to Cardiocel https://www.proactiveinvestors.com/companies/news/147918/allied-healthcare-more-surgeons-opt-for-early-access-to-cardiocel-41690.html Sun, 07 Apr 2013 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147918/allied-healthcare-more-surgeons-opt-for-early-access-to-cardiocel-41690.html Allied Healthcare lodges U.S. premarket notification for heart tissue patch https://www.proactiveinvestors.com/companies/news/147917/allied-healthcare-lodges-us-premarket-notification-for-heart-tissue-patch--41456.html Tue, 02 Apr 2013 01:25:00 -0400 https://www.proactiveinvestors.com/companies/news/147917/allied-healthcare-lodges-us-premarket-notification-for-heart-tissue-patch--41456.html Allied Healthcare Group’s CardioCel® trial positive with no calcification after four years https://www.proactiveinvestors.com/companies/news/147916/allied-healthcare-groups-cardiocel-trial-positive-with-no-calcification-after-four-years--40438.html Wed, 06 Mar 2013 00:40:00 -0500 https://www.proactiveinvestors.com/companies/news/147916/allied-healthcare-groups-cardiocel-trial-positive-with-no-calcification-after-four-years--40438.html Allied Healthcare Group rated ‘outperform’ by RBS Morgans, $0.061 price target https://www.proactiveinvestors.com/companies/news/147915/allied-healthcare-group-rated-outperform-by-rbs-morgans-0061-price-target-40053.html Tue, 26 Feb 2013 03:55:00 -0500 https://www.proactiveinvestors.com/companies/news/147915/allied-healthcare-group-rated-outperform-by-rbs-morgans-0061-price-target-40053.html Allied Healthcare Group closer to CE Mark approval for CardioCel® https://www.proactiveinvestors.com/companies/news/147914/allied-healthcare-group-closer-to-ce-mark-approval-for-cardiocel--39492.html Wed, 13 Feb 2013 00:20:00 -0500 https://www.proactiveinvestors.com/companies/news/147914/allied-healthcare-group-closer-to-ce-mark-approval-for-cardiocel--39492.html Allied Healthcare Group looks for further revenue growth in 2013 https://www.proactiveinvestors.com/companies/news/147913/allied-healthcare-group-looks-for-further-revenue-growth-in-2013-38864.html Wed, 30 Jan 2013 00:20:00 -0500 https://www.proactiveinvestors.com/companies/news/147913/allied-healthcare-group-looks-for-further-revenue-growth-in-2013-38864.html Allied Healthcare Group completes A$4.6M raising to launch CardioCel® https://www.proactiveinvestors.com/companies/news/147912/allied-healthcare-group-completes-a46m-raising-to-launch-cardiocel-38604.html Wed, 23 Jan 2013 00:30:00 -0500 https://www.proactiveinvestors.com/companies/news/147912/allied-healthcare-group-completes-a46m-raising-to-launch-cardiocel-38604.html Allied Healthcare Group unlocks further potential of regenerative tissue technology https://www.proactiveinvestors.com/companies/news/147911/allied-healthcare-group-unlocks-further-potential-of-regenerative-tissue-technology--37997.html Thu, 10 Jan 2013 00:30:00 -0500 https://www.proactiveinvestors.com/companies/news/147911/allied-healthcare-group-unlocks-further-potential-of-regenerative-tissue-technology--37997.html Allied Healthcare Group: Coridon’s Ian Frazer receives grant for HPV vaccine development https://www.proactiveinvestors.com/companies/news/147910/allied-healthcare-group-coridons-ian-frazer-receives-grant-for-hpv-vaccine-development-37568.html Thu, 20 Dec 2012 00:58:00 -0500 https://www.proactiveinvestors.com/companies/news/147910/allied-healthcare-group-coridons-ian-frazer-receives-grant-for-hpv-vaccine-development-37568.html Allied Healthcare Group completes oversubscribed A$1.7M capital raising https://www.proactiveinvestors.com/companies/news/147909/allied-healthcare-group-completes-oversubscribed-a17m-capital-raising--37378.html Mon, 17 Dec 2012 00:31:00 -0500 https://www.proactiveinvestors.com/companies/news/147909/allied-healthcare-group-completes-oversubscribed-a17m-capital-raising--37378.html Allied Healthcare Group to raise capital https://www.proactiveinvestors.com/companies/news/147908/allied-healthcare-group-to-raise-capital-37267.html Wed, 12 Dec 2012 23:10:00 -0500 https://www.proactiveinvestors.com/companies/news/147908/allied-healthcare-group-to-raise-capital-37267.html Allied Healthcare Group proves heart patch capable of tissue regeneration https://www.proactiveinvestors.com/companies/news/147907/allied-healthcare-group-proves-heart-patch-capable-of-tissue-regeneration--36493.html Wed, 28 Nov 2012 01:10:00 -0500 https://www.proactiveinvestors.com/companies/news/147907/allied-healthcare-group-proves-heart-patch-capable-of-tissue-regeneration--36493.html Allied Healthcare Group highlights success of Coridon’s HPV vaccine https://www.proactiveinvestors.com/companies/news/147906/allied-healthcare-group-highlights-success-of-coridons-hpv-vaccine--35910.html Thu, 15 Nov 2012 01:00:00 -0500 https://www.proactiveinvestors.com/companies/news/147906/allied-healthcare-group-highlights-success-of-coridons-hpv-vaccine--35910.html Allied Healthcare Group new contract win, a portent of further growth https://www.proactiveinvestors.com/companies/news/147905/allied-healthcare-group-new-contract-win-a-portent-of-further-growth--35530.html Tue, 06 Nov 2012 23:50:00 -0500 https://www.proactiveinvestors.com/companies/news/147905/allied-healthcare-group-new-contract-win-a-portent-of-further-growth--35530.html Allied Healthcare Group’s cardiovascular tissue patch implanted in first patients https://www.proactiveinvestors.com/companies/news/147904/allied-healthcare-groups-cardiovascular-tissue-patch-implanted-in-first-patients--34644.html Thu, 18 Oct 2012 00:46:00 -0400 https://www.proactiveinvestors.com/companies/news/147904/allied-healthcare-groups-cardiovascular-tissue-patch-implanted-in-first-patients--34644.html Allied Healthcare Group’s cardiovascular tissue patch authorised by TGA for early use https://www.proactiveinvestors.com/companies/news/147903/allied-healthcare-groups-cardiovascular-tissue-patch-authorised-by-tga-for-early-use-33838.html Tue, 25 Sep 2012 23:34:00 -0400 https://www.proactiveinvestors.com/companies/news/147903/allied-healthcare-groups-cardiovascular-tissue-patch-authorised-by-tga-for-early-use-33838.html Allied Healthcare Group receives Buy Recommendation from RBS Morgans https://www.proactiveinvestors.com/companies/news/147902/allied-healthcare-group-receives-buy-recommendation-from-rbs-morgans-33060.html Tue, 04 Sep 2012 03:14:00 -0400 https://www.proactiveinvestors.com/companies/news/147902/allied-healthcare-group-receives-buy-recommendation-from-rbs-morgans-33060.html Allied Healthcare Group increases commercial potential of ADAPT® technology with CSIRO partnership https://www.proactiveinvestors.com/companies/news/147901/allied-healthcare-group-increases-commercial-potential-of-adapt-technology-with-csiro-partnership-30822.html Mon, 02 Jul 2012 23:26:00 -0400 https://www.proactiveinvestors.com/companies/news/147901/allied-healthcare-group-increases-commercial-potential-of-adapt-technology-with-csiro-partnership-30822.html Allied Healthcare Group moves closer to commercialisation of cardiovascular patch https://www.proactiveinvestors.com/companies/news/147900/allied-healthcare-group-moves-closer-to-commercialisation-of-cardiovascular-patch-29711.html Mon, 04 Jun 2012 23:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147900/allied-healthcare-group-moves-closer-to-commercialisation-of-cardiovascular-patch-29711.html Allied Healthcare Group adds former CSL executive’s expertise to board https://www.proactiveinvestors.com/companies/news/147899/allied-healthcare-group-adds-former-csl-executives-expertise-to-board-29059.html Sun, 20 May 2012 22:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147899/allied-healthcare-group-adds-former-csl-executives-expertise-to-board-29059.html Allied Healthcare Group substantial shareholder The Metal Group moves to 17.84% interest https://www.proactiveinvestors.com/companies/news/147898/allied-healthcare-group-substantial-shareholder-the-metal-group-moves-to-1784-interest--28376.html Tue, 01 May 2012 22:10:00 -0400 https://www.proactiveinvestors.com/companies/news/147898/allied-healthcare-group-substantial-shareholder-the-metal-group-moves-to-1784-interest--28376.html Allied Healthcare Group increases stake in Coridon to 44% https://www.proactiveinvestors.com/companies/news/147897/allied-healthcare-group-increases-stake-in-coridon-to-44--28164.html Thu, 26 Apr 2012 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147897/allied-healthcare-group-increases-stake-in-coridon-to-44--28164.html Allied Healthcare Group well supported by market, raises $2m to increase Coridon ownership https://www.proactiveinvestors.com/companies/news/147896/allied-healthcare-group-well-supported-by-market-raises-2m-to-increase-coridon-ownership-28101.html Wed, 25 Apr 2012 22:23:00 -0400 https://www.proactiveinvestors.com/companies/news/147896/allied-healthcare-group-well-supported-by-market-raises-2m-to-increase-coridon-ownership-28101.html Allied Healthcare Group: Coridon secures licence to vector technology https://www.proactiveinvestors.com/companies/news/147895/allied-healthcare-group-coridon-secures-licence-to-vector-technology-27710.html Mon, 16 Apr 2012 23:20:00 -0400 https://www.proactiveinvestors.com/companies/news/147895/allied-healthcare-group-coridon-secures-licence-to-vector-technology-27710.html Allied Healthcare Group further proves up commercial benefits of tissue technology https://www.proactiveinvestors.com/companies/news/147894/allied-healthcare-group-further-proves-up-commercial-benefits-of-tissue-technology--27359.html Thu, 05 Apr 2012 00:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147894/allied-healthcare-group-further-proves-up-commercial-benefits-of-tissue-technology--27359.html Allied Healthcare Group advances towards clinical trials of ADAPT® technology with further success https://www.proactiveinvestors.com/companies/news/147893/allied-healthcare-group-advances-towards-clinical-trials-of-adapt-technology-with-further-success-27040.html Wed, 28 Mar 2012 23:35:00 -0400 https://www.proactiveinvestors.com/companies/news/147893/allied-healthcare-group-advances-towards-clinical-trials-of-adapt-technology-with-further-success-27040.html Allied Healthcare Group granted Singapore patent, boosts commercial prospects for ADAPT® https://www.proactiveinvestors.com/companies/news/147892/allied-healthcare-group-granted-singapore-patent-boosts-commercial-prospects-for-adapt--26583.html Sun, 18 Mar 2012 23:30:00 -0400 https://www.proactiveinvestors.com/companies/news/147892/allied-healthcare-group-granted-singapore-patent-boosts-commercial-prospects-for-adapt--26583.html Allied Healthcare Group to boost kitty by A$6.36m to advance Coridon vaccines https://www.proactiveinvestors.com/companies/news/147891/allied-healthcare-group-to-boost-kitty-by-a636m-to-advance-coridon-vaccines-26521.html Fri, 16 Mar 2012 00:00:00 -0400 https://www.proactiveinvestors.com/companies/news/147891/allied-healthcare-group-to-boost-kitty-by-a636m-to-advance-coridon-vaccines-26521.html Allied Healthcare Group soon to release capital raising announcement, granted halt https://www.proactiveinvestors.com/companies/news/147890/allied-healthcare-group-soon-to-release-capital-raising-announcement-granted-halt--26391.html Tue, 13 Mar 2012 23:40:00 -0400 https://www.proactiveinvestors.com/companies/news/147890/allied-healthcare-group-soon-to-release-capital-raising-announcement-granted-halt--26391.html Allied Healthcare Group successfully implants cardiovascular patch for valve reconstruction https://www.proactiveinvestors.com/companies/news/147889/allied-healthcare-group-successfully-implants-cardiovascular-patch-for-valve-reconstruction--26338.html Mon, 12 Mar 2012 23:44:00 -0400 https://www.proactiveinvestors.com/companies/news/147889/allied-healthcare-group-successfully-implants-cardiovascular-patch-for-valve-reconstruction--26338.html Allied Healthcare Group advances regulatory approval https://www.proactiveinvestors.com/companies/news/147888/allied-healthcare-group-advances-regulatory-approval--26057.html Mon, 05 Mar 2012 07:00:00 -0500 https://www.proactiveinvestors.com/companies/news/147888/allied-healthcare-group-advances-regulatory-approval--26057.html Allied Healthcare Group: Coridon targets $1.5b HPV market, developing next generation vaccine https://www.proactiveinvestors.com/companies/news/147887/allied-healthcare-group-coridon-targets-15b-hpv-market-developing-next-generation-vaccine-25764.html Tue, 28 Feb 2012 00:47:00 -0500 https://www.proactiveinvestors.com/companies/news/147887/allied-healthcare-group-coridon-targets-15b-hpv-market-developing-next-generation-vaccine-25764.html Allied Healthcare Group: Dr Julian Chick to fill the chief operating officer’s seat https://www.proactiveinvestors.com/companies/news/147886/allied-healthcare-group-dr-julian-chick-to-fill-the-chief-operating-officers-seat-23177.html Wed, 07 Dec 2011 06:32:00 -0500 https://www.proactiveinvestors.com/companies/news/147886/allied-healthcare-group-dr-julian-chick-to-fill-the-chief-operating-officers-seat-23177.html Allied Healthcare Group technology could extend implanted tissue lifespan, in distribution talks https://www.proactiveinvestors.com/companies/news/147885/allied-healthcare-group-technology-could-extend-implanted-tissue-lifespan-in-distribution-talks--22979.html Sun, 04 Dec 2011 23:30:00 -0500 https://www.proactiveinvestors.com/companies/news/147885/allied-healthcare-group-technology-could-extend-implanted-tissue-lifespan-in-distribution-talks--22979.html Allied Healthcare Group: Broker places "Speculative Buy," $0.10 price target https://www.proactiveinvestors.com/companies/news/147884/allied-healthcare-group-broker-places-speculative-buy-010-price-target--22862.html Thu, 01 Dec 2011 05:16:00 -0500 https://www.proactiveinvestors.com/companies/news/147884/allied-healthcare-group-broker-places-speculative-buy-010-price-target--22862.html Allied Healthcare Group appoints key executive to biotechnology company, Celxcel https://www.proactiveinvestors.com/companies/news/147883/allied-healthcare-group-appoints-key-executive-to-biotechnology-company-celxcel-22380.html Mon, 21 Nov 2011 22:35:00 -0500 https://www.proactiveinvestors.com/companies/news/147883/allied-healthcare-group-appoints-key-executive-to-biotechnology-company-celxcel-22380.html Allied Healthcare Group on the cusp of building a global healthcare company https://www.proactiveinvestors.com/companies/news/147882/allied-healthcare-group-on-the-cusp-of-building-a-global-healthcare-company--22209.html Fri, 18 Nov 2011 01:18:00 -0500 https://www.proactiveinvestors.com/companies/news/147882/allied-healthcare-group-on-the-cusp-of-building-a-global-healthcare-company--22209.html Allied Healthcare Group reports on Coridon testing against Herpes Simplex Virus 2 using DNA vaccine https://www.proactiveinvestors.com/companies/news/147881/allied-healthcare-group-reports-on-coridon-testing-against-herpes-simplex-virus-2-using-dna-vaccine-20571.html Mon, 10 Oct 2011 23:10:00 -0400 https://www.proactiveinvestors.com/companies/news/147881/allied-healthcare-group-reports-on-coridon-testing-against-herpes-simplex-virus-2-using-dna-vaccine-20571.html